A four-year, $2.4 million grant will help U engineering researchers test how changes in shape damage cells and explore ...

Please provide your email address to receive an email when new articles are posted on . Studies, case reports and personal experience highlight the utility of the allograft. A company official called ...

LEXINGTON, KY / ACCESSWIRE / April 18, 2023 / Brightstar Therapeutics, a biotechnology company focused on providing innovative treatment options for corneal and ocular surface diseases, announced the ...

Hong Kong start-up GenEditBio is testing a one-shot gene-editing therapy for TGFBI-related corneal dystrophies, inherited ...

Please provide your email address to receive an email when new articles are posted on . Neuropathy and inflammation work together to drive common manifestations of corneal disease. Early intervention ...

A cornea transplant, or keratoplasty, is an operation to replace part of the cornea with corneal tissue from a donor. The cornea is the transparent, dome-shaped surface of the eye. Light enters the ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation's Epioxa, offering patients living with a rare corneal disease a treatment option that does not require incisions. Epioxa, ...

University of Waterloo researchers have discovered how tiny bumps inside the eye contribute to Fuchs endothelial corneal ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Rare eye diseases are the leading cause of untreatable blindness in Europe and affect people of all ages. The RESTORE VISION scientific team has identified seven rare ocular conditions that impact the ...

Studying mice, researchers have found that proteins made by stem cells to help regenerate the cornea may become new targets for treating and preventing injuries to the cornea related to dry eye ...